A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

NCT01847274 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

596

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Platinum Sensitive Ovarian Cancer

Interventions

DRUG: Active comparator: Niraparib
DRUG: placebo

Sponsor

Tesaro, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]